The method that stimulates mucosal immunity protects the body from age-related diseases (e.g. pulmonary fibrosis), and age-related comorbidities, including hair loss, ocular lens clouding, decreased bone density, decreased bone marrow stem cell activity, as well as decreased immune and cognitive functions. MSP-102 are innovative geroprotective inventions designed from microbiome-related materials that improve aging phenomena. By utilizing MSP-201 and MSP-306, we have generated a suite of novel drug development program targeting diverse age-related diseases such as NASH, IBD, IPF, cancers, etc. We have a large number of licenses with material and method of use patents, and we are continuously developing our pipeline to expand our patents.